课题基金 / 基金详情

ROLE OF DOPAMINE METABOLISM IN ANTIDEPRESSANT EFFECT OF SLEEP DEPRIVATION

ROLE OF DOPAMINE METABOLISM IN ANTIDEPRESSANT EFFECT OF SLEEP DEPRIVATION
多巴胺代谢在睡眠剥夺的抗抑郁作用中的作用
批准号:
7374191
负责人:
John R. Kelsoe
金额:
$3.99万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2006-11-30

项目摘要

项目成果

John R. Kelsoe的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine if the antidepressant effect of sleep deprivation can be made to last longer through the use of medications, change in bedtime and treatment with light. For many patients staying up all night without sleep can immediately improve their depression the next day. The problem is that once the person goes to sleep again the next night, they become depressed again. No other treatment for depression has such an immediate effect. Investigators will test to see if the beneficial effect of sleep deprivation can be extended by adding two additional treatments, an earlier bedtime on the two following nights and exposure to bright light. This will be compared to the usual form of treatment using the antidepressant medication, sertraline, and the mood stabilizing medication, lithium, to see if they are better. PET will be used to study the activity of the brain and the role of a brain chemical or neurotransmitter dopamine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder
Genetic Predictors of Lithium Response in Bipolar Disorder
  • 批准号:
    8196309
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2010
  • 负责人:
    John R. Kelsoe
  • 依托单位:
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder
国内基金
海外基金
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
  • 批准号:
    82371144
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    汪雪玲
  • 依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
KLK10调控胶质—血管耦合与对话促缺血性卒中后血脑屏障修复的机制
  • 批准号:
    82371465
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李龙宣
  • 依托单位:
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
  • 批准号:
    81801389
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2018
  • 负责人:
    田茗源
  • 依托单位: